<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60430">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02319252</url>
  </required_header>
  <id_info>
    <org_study_id>Tubes in liver diseases</org_study_id>
    <nct_id>NCT02319252</nct_id>
  </id_info>
  <brief_title>Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases</brief_title>
  <official_title>Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is an unblinded randomized trial, designed to examine whether gastric- or jejunal
      feeding tubes are the most effect full to feed patients with alcoholic liver diseases and
      non-sufficient oral intake.

      The primary outcome will be differences in nutrition intake between the groups. Secondary
      outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients'
      quality of life, nausea &amp; vomiting.

      The study will include 40 patients at Aarhus University Hospital, Denmark.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in nutrition intake</measure>
    <time_frame>Day 3 &amp; 7 and every 7th. day until discharge from the hospital, up to 3 months</time_frame>
    <description>Nutrition intake, protein intake, oral intake versus tube intake</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in patients reported outcomes</measure>
    <time_frame>Day 3 &amp; 7 and every 7th. day until discharge from the hospital, up to 3 months</time_frame>
    <description>Questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Malnutrition</condition>
  <condition>Liver Diseases, Alcoholic</condition>
  <arm_group>
    <arm_group_label>Gastric tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A gastric tube is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jejunal tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A jejunal tube is used</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Gastric tube (Nutricia Flocare® Pur Tube Enlock)</intervention_name>
    <description>Nutricia Flocare® Pur Tube Enlock, Ch. 12</description>
    <arm_group_label>Gastric tube</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Jejunal tube (Nutricia Flocare® Bengmark®)</intervention_name>
    <description>Nutricia Flocare® Bengmark®, Ch. 10</description>
    <arm_group_label>Jejunal tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alcoholic liver disease

          -  nutrition intake less than 75% of needed intake

          -  Signed informed consent form

        Exclusion Criteria:

          -  Hepatic encephalopathy, grade 3 - 4

          -  Anatomic barriers to have a tube placed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Palle Bager, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Palle Bager, PhD</last_name>
    <phone>0045 51500697</phone>
    <email>pallbage@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niels K Aagaard, PhD</last_name>
    <phone>0045 78462866</phone>
    <email>nielaaga@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Central region</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Palle Bager, Ph.d</last_name>
      <phone>51500697</phone>
      <email>pallbage@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Niels K Aagaard, Ph.d</last_name>
      <phone>78462866</phone>
      <email>nielaaga@rm.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 13, 2016</lastchanged_date>
  <firstreceived_date>December 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Liver Diseases, Alcoholic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
